Murphy Canyon Acquisition Corp. (NASDAQ:MURFW) is a blank check company whose primary business is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with a target focus on the real estate industry including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, as well as adjacent businesses and technologies targeting the real estate space with an aggregate enterprise value of approximately $300 million to $1.2 billion. The company offers no current products or services beyond its SPAC structure and public warrants exercisable at $11.50 per share. Founded in 2021 and headquartered in San Diego, California, it operates principally in the United States. In September 2023, Murphy Canyon completed a business combination with Conduit Pharmaceuticals Limited, a clinical-stage life science company, resulting in the SPAC changing its name to Conduit Pharmaceuticals Inc. (NASDAQ:CDT), with its common stock and new warrants (CDTTW) commencing trading under those tickers while separating the original warrants (MURFW) for continued independent trading; the deal provided Conduit approximately $20 million in net proceeds after redemptions via a concurrent private placement offering of units. As of late 2025, Murphy Canyon Acquisition Corp. remains a micro-cap entity trading under its legacy ticker symbols with ongoing market activity in its warrants, reporting quarterly net losses and negative financial metrics amid a potentially inactive or delisted status for certain classes, sponsored by Presidio Property Trust which retained equity in the post-merger Conduit entity.